Abstract:For the immune system to function properly, the activation of leukocytes must be tightly regulated. Failures of immune control mechanisms underlie the aberrant targeting of self‐antigens (i.e. autoimmunity) and the collateral damage of healthy tissues during excessive responses to infectious threats or the unnecessary immune mobilization against innocuous commensal microbes. Foxp3‐expressing CD4+ Regulatory T cells (Tregs) are a major cellular force working to prevent these pathologies of immune dysregulation. These cells characteristically exhibit multiple suppressive function that is absolutely required for the maintenance of immune homeostasis. However, these cells can hamper desirable anti‐tumor immune responses in cancer patients. Accordingly, a relative abundance of Tregs in the tumor microenvironment (TME) is a negative prognostic factor in many cancers. Treg‐depleting or antagonizing strategies show promise as potential interventions capable of unleashing anti‐tumor immunity from suppression. The characteristic gene expression and suppressive function of Tregs depend considerably on the stable expression and activity of the transcription factor FOXP3. While transcriptional regulation of the Foxp3gene has been studied in depth, both the expression and function of this factor are also modulated at the protein level. However, the molecular players involved in posttranslational FOXP3 regulation are just beginning to be elucidated. We have found that in the absence of the E3 ligase TRAF6 Tregs were dysfunctional in vivo. In these studies, mice with Treg‐restricted deletion of TRAF6 were highly resistant to implanted tumors and displayed enhanced anti‐tumor immunity. We further determined that FOXP3 undergoes lysine‐63 linked (K63) ubiquitination at lysine 262, and this posttranslational modification was mediated by TRAF6. When deprived of TRAF6 activity or rendered insensitive to K63 ubiquitination, FOXP3 displayed aberrant, perinuclear accumulation and disrupted regulatory function. Thus, K63 ubiquitination by TRAF6 ensures proper localization of FOXP3 and facilitates the transcription factor's gene‐regulating activity in Tregs. These results implicate TRAF6 as a key, hitherto unappreciated posttranslational facilitator of FOXP3 stabilization and Treg suppressive function that may be targeted by novel tolerance‐breaking immunotherapies to improve anti‐tumor immunity and combat disease progression in cancer patients.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

E3 Ubiquitin Ligase Vhl Regulates Hypoxia-Inducible Factor-1 Alpha To Maintain Regulatory T Cell Stability And Suppressive Capacity

Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells

The E3 Ligase VHL Promotes Follicular Helper T Cell Differentiation Via Glycolytic-Epigenetic Control.

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity

E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function Via Glycolysis Inhibition and Induction of Interleukin-33 Receptor.

The E3 Ligase VHL Controls Lung Inflammation by Regulating Epithelium-ILC2 Cross-talk

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

TIF1γ regulates stability of T regulatory cells during inflammation

The E3 Ligase VHL Controls Alveolar Macrophage Function Via Metabolic-Epigenetic Regulation

pVHL regulates protein stability of TCF/LEF transcription factor family via ubiquitin-independent proteasomal degradation

FOXP3 exon 2 controls T reg stability and autoimmunity

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

Autocrine TGF-β1 Maintains the Stability of Foxp3+ Regulatory T Cells via IL-12Rβ2 Downregulation

IdentifICATION OF E3 Ubiquitin Ligase STUB1 As a Negative Regulator of FOXP3

CXXC-finger protein 1 associates with FOXP3 to stabilize homeostasis and suppressive functions of regulatory T cells

Tcf1 and Lef1 Are Required for the Immunosuppressive Function of Regulatory T Cells

The E3 Ubiquitin Ligase Itch Regulates Expression of Transcription Factor Foxp3 and Airway Inflammation by Enhancing the Function of Transcription Factor TIEG1.

GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg.

Transcription Factors Foxo3a and Foxo1 Couple the E3 Ligase Cbl-b to the Induction of Foxp3 Expression in Induced Regulatory T Cells

The E3 Ligase TRAF6 Directs FOXP3 Localization and Facilitates Treg Function Through K63‐type Ubiquitination